Evidence map›Paper›PMID 37954080›Full record

ArticleFrontiers in oncology2023

CT-based dosiomics and radiomics model predicts radiation-induced lymphopenia in nasopharyngeal carcinoma patients.

Qingfang Huang, Chao Yang, Jinmeng Pang, Biao Zeng, Pei Yang, Rongrong Zhou, Haijun Wu, Liangfang Shen, Rong Zhang, Fan Lou and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Qingfang HuangDepartment of Radiation Oncology Hunan Cancer Hospital/The Affiliated Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China.
Chao YangDepartment of Radiation Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jinmeng PangDepartment of Radiation Oncology Hunan Cancer Hospital/The Affiliated Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China.
Biao ZengDepartment of Radiation Oncology Hunan Cancer Hospital/The Affiliated Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China.
Pei YangDepartment of Radiation Oncology Hunan Cancer Hospital/The Affiliated Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China.
Rongrong ZhouDepartment of Radiation Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Haijun WuDepartment of Radiation Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Liangfang ShenDepartment of Radiation Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Rong ZhangDepartment of Radiation Oncology Hunan Cancer Hospital/The Affiliated Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China.
Fan LouDepartment of Radiation Oncology Hunan Cancer Hospital/The Affiliated Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China.
Yi JinDepartment of Radiation Oncology Hunan Cancer Hospital/The Affiliated Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China.
Albert AbdilimDepartment of Radiation Oncology Hunan Cancer Hospital/The Affiliated Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China.
Hekun JinDepartment of Radiation Oncology Hunan Cancer Hospital/The Affiliated Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China.
Zijian ZhangDepartment of Radiation Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xiaoxue XieDepartment of Radiation Oncology Hunan Cancer Hospital/The Affiliated Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China.
Central South University · CNHunan Cancer Hospital · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aims to develop and validate a model predictive for the incidence of grade 4 radiation-induced lymphopenia (G4RIL), based on dosiomics features and radiomics features from the planning CT of nasopharyngeal carcinoma (NPC) treated by radiation therapy. Methods: The dataset of 125 NPC patients treated with radiotherapy from August 2018 to March 2019 was randomly divided into two sets-an 85-sample training set and a 40-sample test set. Dosiomics features and radiomics features of the CT image within the skull bone and cervical vertebrae were extracted. A feature selection process of multiple steps was employed to identify the features that most accurately forecast the data and eliminate superfluous or insignificant ones. A support vector machine learning classifier with correction for imbalanced data was trained on the patient dataset for prediction of RIL (positive classifier for G4RIL, negative otherwise). The model's predictive capability was gauged by gauging its sensitivity (the likelihood of a positive test being administered to patients with G4RIL) and specificity in the test set. The area beneath the ROC curve (AUC) was utilized to explore the association of characteristics with the occurrence of G4RIL. Results: Three clinical features, three dosiomics features, and three radiomics features exhibited significant correlations with G4RIL. Those features were then used for model construction. The combination model, based on nine robust features, yielded the most impressive results with an ACC value of 0.88 in the test set, while the dosiomics model, with three dosiomics features, had an ACC value of 0.82, the radiomics model, with three radiomics features, had an ACC value of 0.82, and the clinical model, with its initial features, had an ACC value of 0.6 for prediction performance. Conclusion: The findings show that radiomics and dosiomics features are correlated with the G4RIL of NPC patients. The model incorporating radiomics features and dosiomics features from planning CT can predict the incidence of G4RIL in NPC patients.

Indexed as

dosiomicsmachine learningnasopharyngeal carcinomaradiation-induced lymphopeniaradiomics

Identifiers

PMID37954080
PMCPMC10634512
OpenAlexW4388197034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.